Stock listing
9PT Stock Price, News, Filings & Events — Pliant Therapeutics, Inc.
Selected listing: 9PT · MUN · EUR · DE
This page tracks Pliant Therapeutics, Inc.'s 9PT:MUN listing on MUN in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 9PT:MUN. 9PT:MUN is the stock-level entry point for investors researching Pliant Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 9PT:MUN
- Asset type
- Stock
- Market cap
- $72.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- MUN
- Currency
- EUR
Pliant Therapeutics, Inc. 9PT:MUN stock context
This page tracks Pliant Therapeutics, Inc.'s 9PT:MUN listing on MUN in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 9PT:MUN. 9PT:MUN is the stock-level entry point for investors researching Pliant Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Pliant Therapeutics, Inc.
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refract...
August 18, 2026
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
August 11, 2026
Pliant Therapeutics Names Flavia Borellini, Ph.D. and Robert Iannone, M.D., M.S.C.E. to Board of Directors
July 13, 2026
Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
May 21, 2026
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 11, 2026
Research Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for 9PT:MUN.
Pliant Therapeutics, Inc. company profile
View the public company page for Pliant Therapeutics, Inc. on 6ix.
Pliant Therapeutics, Inc. news
Read company news and market updates connected to Pliant Therapeutics, Inc..
Pliant Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Pliant Therapeutics, Inc..
Alternate listings
PLRX:NASDAQ
US · USD
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is 9PT:MUN.
A2P4YV:LSX
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is 9PT:MUN.
A2P4YV:LS
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is 9PT:MUN.
PLRX:BOATS
US · USD
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is 9PT:MUN.
9PT:GETTEX
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is 9PT:MUN.
9PT:DUS
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is 9PT:MUN.
9PT:FWB
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is 9PT:MUN.
9PT:SWB
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is 9PT:MUN.
9PT:TRADEGATE
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is 9PT:MUN.